Gibco CO2 Independent Medium contains a unique buffering system composed of mono and dibasic sodium phosphate and β-glycerophosphate. A small amount of sodium bicarbonate has been included in the formulation to meet essential bicarbonate dependent functions. No synthetic buffers are utilized, thus eliminating any cytotoxic effects associated with such buffering systems. Additionally, Gibco CO2 Independent Medium has been formulated with components that enhance cellular production and utilization of CO2 such that an exogenous source of CO2 is not required for the maintenance of CO2 dependent cellular functions.

Product Use：
For research use only: Not intended for human or animal diagnostic or therapeutic uses.

Dual-Site cGMP Manufacturing：
Gibco CO2 Independent Medium is manufactured at a cGMP compliant facility, located in Grand Island, New York. The facility is registered with the FDA as a medical device manufacturer and is certified to ISO 13485 standards. For supply chain continuity, Life Technologies offers an identical Gibco CO2 Independent Medium product made in our Scotland facility (18045-054). This facility is registered with the FDA as a medical device manufacturer and is certified to the ISO 13485 standard.

CO2 Independent Medium contains no lipids or growth factors. Therefore, CO2 Independent Medium requires supplementation, commonly with 10% Fetal Bovine Serum (FBS). The CO2 Independent Medium does not require a CO2 environment to maintain physiological pH. For maximum growth performance some cell lines may require either direct or sequential adaptation to CO2 Independent Medium .